Hearing and Brain Development in Children and Teens
Official title: A Longitudinal Cohort Study of Hearing and Brain Development in Children and Adolescents With Hearing Loss Across Different Hearing Management Pathways and in Normal-Hearing Controls
Run by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · NCT07625462 · Data updated 2026-11-12
This observational study tests how hearing care paths (like hearing aids, cochlear implants, brainstem implants, gene therapy, or no intervention) relate to hearing, speech, language, and brain development in kids and teens, with a normal-hearing group for comparison.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | May 20, 2026 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT07625462 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children and adolescents up to 18 years old with hearing loss, including those using hearing aids, cochlear implants, auditory brainstem implants, gene therapy, or those managed with follow-up or normal-hearing controls.
✕Probably not a fit
Children who cannot participate in study testing or who have conditions that obscure developmental assessments may not benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort will follow children and adolescents with hearing loss across multiple management pathways and compare them to a normal-hearing group. Participants will undergo repeated assessments of hearing, speech and language skills, neurodevelopment, and multimodal brain function over time. The study aims to map development trajectories and how different interventions may influence outcomes. It does not assign treatments but observes existing management choices and their associations with outcomes.
Why it matters
Potential benefit: If successful, the study could help identify which management pathways are associated with the best developmental outcomes in children with hearing loss.
How similar studies have gone: Previous observational cohorts have provided insights into hearing development, but this study’s broad, bidirectional design across multiple interventions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age no more than 18 years. * For the HA/CI/ABI/GT/FU groups: behavioral or pure-tone hearing threshold \>=20 dB HL, or air-conduction ABR \>=35 dB nHL; For the normal-hearing control group: participants diagnosed as normal hearing by experienced physicians. Exclusion Criteria: * Inability to cooperate with study testing procedures.
Where it's running
-
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China Recruiting
Study contacts
- Principal investigator: Hao Wu — Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
- Study coordinator: Yun Li
- Email: liyuncmm@126.com
- Phone: +86-21-53314064
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
WhatsApp AI support vs paper support for first-time hearing aid users
This study tests whether a WhatsApp-based AI support program helps adults with new hearing aids in LMIC communities use and feel confident about their devices better than a paper pamphlet.
-
Web-based auditory training with easy versus hard task settings to improve speech and listening
This project will test whether easy or hard versions of a web-based auditory training program help adults with hearing loss improve speech understanding and everyday listening.
-
Long-term hearing and speech outcomes after cochlear implants
This project will see if cochlear implants improve hearing, speech understanding, and quality of life in Mandarin-speaking patients of all ages before and after surgery.
-
Clemastine plus engineered sound to improve hearing in noisy environments for age-related central auditory processing disorder
This trial will test whether taking clemastine while listening to engineered sounds helps people aged 45–65 with age-related central auditory processing disorder hear better in noisy places.
-
Add Pedmark to cisplatin chemotherapy to prevent hearing loss in men with stage II–III metastatic testicular germ cell tumors
We will test whether adding Pedmark to cisplatin chemotherapy reduces hearing damage in men with stage II–III metastatic testicular germ cell tumors.
-
Noninvasive ear stimulation to improve hearing speech in noisy places
This will test whether gentle electrical stimulation of the ear can help people with traumatic brain injury hear speech more clearly in noisy environments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.